Spectral AI, Inc. (Nasdaq: MDAI) ('Spectral AI” or the 'Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care ...

St. Luke’s Medical Center – Global City now operates five advanced Magnetic Resonance Imaging (MRI) systems, forming one of ...

From the importance of looking up ailments to the comfort and cleanliness of hospitals, Roland Bull has experienced both sides of the bed as a patient-turned-doctor ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging ...

HNL Lab Medicine to integrate Ibex’s AI-powered solution for prostate cancer, building on its existing digital pathology ...

AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires.

Duc Giang, Saint Paul, and Hanoi Oncology Hospital. The technology is expected to assist doctors in reading film results and ...

Milestone marks the half-way point of enrollment in pivotal U.S. study designed to support 510(k) submission for the first culture-free, rapid phenotypic ID/AST panel for critically ill pneumonia ...

BEIJING, CHINA - Media OutReach Newswire - 20 March 2026 - China's multifaceted strategy to end the tuberculosis ...

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2025 Earnings Call Transcript March 18, 2026 Hyperfine, Inc. beats earnings expectations. Reported EPS is $-0.06276, expectations were $-0.08. Operator: Hello, and ...

The Urocross® Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.

ASX-listed healthcare companies are increasingly teaming up with universities to fast-track new therapies, combining academic research with clinical and commercial ... Read More The post ASX ...